$670.9M
Total Value
2
Total Contracts
Drugs and Pharmaceutical
Primary Category
Recent Contracts
Active
Drugs and Pharmaceutical
CN4171505—Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)$317.7M
30 June 2025 - 29 June 2028
Expired
Drugs and Pharmaceutical
CN3727716—Supply of Hemlibra$353.2M
31 Oct 2020 - 29 June 2025
Peer Benchmarking
Financial Year Breakdown
FY26
$317.7M(1 contracts)
FY21
$353.2M(1 contracts)
Company Details
- Name
- ROCHE PRODUCTS PTY LTD
- Also known as
- Roche Foundation Medicine
- Entity Type
- Australian Private Company
- ABN
- 70 000 132 865
- Town/City
- Sydney
- Postcode
- 2000
- State/Territory
- NSW
- Country
- Australia